Cite
HARVARD Citation
Ghanim, H. et al. (2021). Dapagliflozin reduces systolic blood pressure and modulates vasoactive factors. Diabetes, obesity & metabolism. 23 (7), pp. 1614-1623. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ghanim, H. et al. (2021). Dapagliflozin reduces systolic blood pressure and modulates vasoactive factors. Diabetes, obesity & metabolism. 23 (7), pp. 1614-1623. [Online].